Skip to main content
NCBI home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1962 Apr;55(4):277–286. doi: 10.1177/003591576205500406

The Drug Treatment of Hypertension

PMCID: PMC1896727  PMID: 13904707

Full text

PDF
277

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. HAMILTON M., HENLEY K. S., MORRISON B. Changes in peripheral circulation and body temperature after hexamethonium bromide. Clin Sci. 1954 May;13(2):225–237. [PubMed] [Google Scholar]
  2. HARINGTON M., KINCAID-SMITH P., McMICHAEL J. Results of treatment in malignant hypertension: a seven-year experience in 94 cases. Br Med J. 1959 Nov 14;2(5158):969–980. doi: 10.1136/bmj.2.5158.969. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. HARINGTON M. The absorption and excretion of hexamethonium salts. Clin Sci. 1953 May;12(2):185–198. [PubMed] [Google Scholar]
  4. HARRIS E., TURNER R. 1-Hydrazinophthalazine (apresoline) in hypertension. Lancet. 1954 Feb 27;266(6809):429–433. doi: 10.1016/s0140-6736(54)91138-1. [DOI] [PubMed] [Google Scholar]
  5. Hodge J. V., McQueen E. G., Smirk H. Results of Hypotensive Therapy in Arterial Hypertension. Br Med J. 1961 Jan 7;1(5218):1–7. doi: 10.1136/bmj.1.5218.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. KITCHIN A., LOWTHER C. P., TURNER R. W. Mecamylamine; a ganglion-blocking drug for treating hypertension. Lancet. 1957 Sep 28;273(6996):605–609. doi: 10.1016/s0140-6736(57)91941-4. [DOI] [PubMed] [Google Scholar]
  7. MORRISON B. Parenteral hexamethonium in hypertension. Br Med J. 1953 Jun 13;1(4823):1291–1299. doi: 10.1136/bmj.1.4823.1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. McMichael J. Reorientations in Hypertensive Disorders-II. Br Med J. 1961 Nov 18;2(5263):1310–1314. doi: 10.1136/bmj.2.5263.1310. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. McQUEEN E. G., DOYLE A. E., SMIRK F. H. The circulatory effects of reserpine. Circulation. 1955 Feb;11(2):161–169. doi: 10.1161/01.cir.11.2.161. [DOI] [PubMed] [Google Scholar]
  10. O'DONNELL T. V. Studies in postural hypotension following ganglion blocking drugs. Clin Sci. 1959 May;18:237–249. [PubMed] [Google Scholar]
  11. PATON W. D. M., ZAIMIS E. J. The pharmacological actions of polymethylene bistrimethyl-ammonium salts. Br J Pharmacol Chemother. 1949 Dec;4(4):381–400. doi: 10.1111/j.1476-5381.1949.tb00565.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. RESTALL P. A., SMIRK F. H. Regulation of blood pressure levels by hexamethonium bromide and mechanical devices. Br Heart J. 1952 Jan;14(1):1–12. doi: 10.1136/hrt.14.1.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. SMIRK F. H., HAMILTON M., DOYLE A. E., McQUEEN E. G. The treatment of hypertensive heart failure and of hypertensive cardiac overload by blood pressure reduction. Am J Cardiol. 1958 Feb;1(2):143–153. doi: 10.1016/0002-9149(58)90045-6. [DOI] [PubMed] [Google Scholar]
  14. SMITH K. S., FOWLER P. B. Prevention and treatment of hypertensive heart-failure by ganglion-blocking agents. Lancet. 1955 Feb 26;268(6861):417–418. doi: 10.1016/s0140-6736(55)90209-9. [DOI] [PubMed] [Google Scholar]
  15. TURNER R. W., LOWTHER C. P. Ganglion-blocking drugs in the management of hypertension. Practitioner. 1961 Jan;186:63–71. [PubMed] [Google Scholar]
  16. VERNIKOS-DANELLIS J., ZAIMIS E. Some pharmacological actions of bretylium and guanethidine. Lancet. 1960 Oct 8;2(7154):787–788. doi: 10.1016/s0140-6736(60)91856-0. [DOI] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES